Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury
Listen to this summary
The authors investigate the role of LAPTM4A, a lysosome-localized protein, in protecting against myocardial ischemia-reperfusion (MIR) injury, a condition that complicates heart revascularization. Their findings reveal that LAPTM4A enhances autophagic flux by interacting with Rubicon, thereby reducing inflammation and cell death during reperfusion. This suggests that targeting LAPTM4A could be a novel therapeutic strategy to mitigate MIR injury.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Circulation
View all →Aug 6, 2026 · Circulation
Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association
Aug 4, 2026 · Circulation
COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34<sup>+</sup> Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis
Aug 4, 2026 · Circulation
Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis
Aug 4, 2026 · Circulation
Loss of the Coronary Artery Disease Risk Gene <em>LMOD1</em> in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis
Aug 3, 2026 · Circulation
Ten Years of Scientific Discovery With the UK Biobank Cardiovascular Magnetic Resonance Imaging Study
Aug 3, 2026 · Circulation
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials: A Scientific Statement From the American Heart Association
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 6, 2026 · JAMA
Iron or Multiple Micronutrient Powder Supplements With Malaria Chemoprevention in Rural Malawian Children: The IRMA Randomized Clinical Trial
Aug 5, 2026 · JAMA
Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial
Aug 5, 2026 · The New England journal of medicine
Syncope
Aug 3, 2026 · JAMA
Classic Hodgkin Lymphoma: A Review
Aug 3, 2026 · JAMA
Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703)
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


